Anti Jo-1 antibodies are the main markers of the antisynthetase syndrome (ASSD), an
autoimmune disease clinically characterized by the occurrence of arthritis, myositis, and interstitial …

Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Background Patients with lower extremity peripheral arterial disease (PAD) and sarcopenia
are a population at risk requiring specific and targeted care. The aim of this review is to …

Systemic sclerosis and autoimmune myositis are both associated with decreased quality of
life and increased mortality. Their prognosis and management largely depend on the disease …

Background: The post-COVID-19 condition, defined as COVID-19-related signs and symptoms
lasting at least 2 months and persisting more than 3 months after infection, appears now …

Introduction/Aims In this study we investigated COVID‐19 vaccination–related adverse
events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory myopathies (IIMs) …

Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD),
an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial …

Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly
understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (…

To evaluate if the timing of appearance with respect to disease onset may influence the arthritis
presentation pattern in antisynthetase syndrome (ASSD). METHODS: The patients were …

Objective Arthritis, myositis and interstitial lung disease (ILD) constitute the classic clinical
triad of anti-synthetase syndrome (ASSD). These patients experience other accompanying …